Stock listing
A14M6X Stock Price, News, Filings & Events — Ascendis Pharma A/s
Selected listing: A14M6X · LS · EUR · DE
This page tracks Ascendis Pharma A/s's A14M6X:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A14M6X:LS. A14M6X:LS is the stock-level entry point for investors researching Ascendis Pharma A/s, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A14M6X:LS
- Asset type
- Stock
- Market cap
- $15.80B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LS
- Currency
- EUR
Ascendis Pharma A/s A14M6X:LS stock context
This page tracks Ascendis Pharma A/s's A14M6X:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A14M6X:LS. A14M6X:LS is the stock-level entry point for investors researching Ascendis Pharma A/s, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Ascendis Pharma A/s
Ascendis Announces Oral Presentation of Week 104 Data from Its Pivotal Trial of TransCon® CNP (Navepegritide) at ISDS 2026
August 25, 2026
Ascendis Pharma Reports Second Quarter 2026 Financial Results
August 13, 2026
Children with Achondroplasia Treated with TransCon CNP Showed Continued Improvements in Lower Extremity Alignment at Week 104 of the Pivo...
June 30, 2026
Ascendis Joins Multiple Russell U.S. Indexes, Including the Russell 3000®, Russell 1000®, Russell 2500® and Russell Midcap®
June 26, 2026
Ascendis to Showcase Advances in Treatment of Achondroplasia at ICCBH 2026
June 25, 2026
Ascendis Pharma A/s earnings calls
Ascendis Pharma A/S (ASND) Q2 2026 Earnings Call
August 13, 2026 · Replay with transcript and chapters
Ascendis Pharma A/S (ASND) Q1 2026 Earnings Call
May 7, 2026 · Replay with transcript and chapters
Ascendis Pharma A/S (ASND) Q4 2025 Earnings Call
February 11, 2026 · Replay with transcript and chapters
Ascendis Pharma A/S (ASND) Q3 2025 Earnings Call
November 12, 2025 · Replay with transcript and chapters
Ascendis Pharma A/S (ASND) Q2 2025 Earnings Call
August 7, 2025 · Replay with transcript and chapters
Ascendis Pharma A/S (ASND) Q1 2025 Earnings Call
May 1, 2025 · Replay with transcript and chapters
Research Ascendis Pharma A/s
Ascendis Pharma A/s investor report
Review AI stock analysis and investor report context for A14M6X:LS.
Ascendis Pharma A/s company profile
View the public company page for Ascendis Pharma A/s on 6ix.
Ascendis Pharma A/s news
Read company news and market updates connected to Ascendis Pharma A/s.
Ascendis Pharma A/s investor events
Find investor webinars, events, and replay context for Ascendis Pharma A/s.
Alternate listings
ASND:NASDAQ
US · USD
Alternate listing for Ascendis Pharma A/s; the primary context on this page is A14M6X:LS.
A14M6X:LSX
DE · EUR
Alternate listing for Ascendis Pharma A/s; the primary context on this page is A14M6X:LS.
A710:GETTEX
DE · EUR
Alternate listing for Ascendis Pharma A/s; the primary context on this page is A14M6X:LS.
ASND:BOATS
US · USD
Alternate listing for Ascendis Pharma A/s; the primary context on this page is A14M6X:LS.
A1SN34:BMFBOVESPA
BR · BRL
Alternate listing for Ascendis Pharma A/s; the primary context on this page is A14M6X:LS.
DK0060606333:LS
DE · EUR
Alternate listing for Ascendis Pharma A/s; the primary context on this page is A14M6X:LS.
ASNDN:BMV
MX · MXN
Alternate listing for Ascendis Pharma A/s; the primary context on this page is A14M6X:LS.
ASNDN:BIVA
MX · MXN
Alternate listing for Ascendis Pharma A/s; the primary context on this page is A14M6X:LS.
ASND1N:BMV
MX · MXN
Alternate listing for Ascendis Pharma A/s; the primary context on this page is A14M6X:LS.
A710:TRADEGATE
DE · EUR
Alternate listing for Ascendis Pharma A/s; the primary context on this page is A14M6X:LS.
A42ANJ:LS
DE · EUR
Alternate listing for Ascendis Pharma A/s; the primary context on this page is A14M6X:LS.
ASND1N:BIVA
MX · MXN
Alternate listing for Ascendis Pharma A/s; the primary context on this page is A14M6X:LS.